Although MEBO International Group is still young, it attained magnificent achievement in less than 20 years and now it is leading the latest development direction in life science and biomedical fields.
In China, more than 150 burn and ulcer technology centers and more than 5,000 cooperative hospitals were established by far. More than 10,000 medical doctors had received formal MEBT/MEBO training and there were over 80 clinical experts extensive burns management experience distributed all over China. Every year over 350,000 extensive burned patients received MEBT/MEBO treatment and attained satisfactory results. In the world, 20,000,000burns patients in more than 20 countries had received successful treatments and MEBT/MEBO was acknowledged by more and more burns experts.
'Human tissue organ regenerative medicine', a new medical system that conforms the life law of human, was established by MEBO and it is contributing more and more to the maintenance and improvement of human health. The success of in situ and in vitro replication and regeneration of human tissue organs indicates the secret of the continual of life is now being unmasked gradually and the door of life is to be opened.
By far, besides skin regeneration, the achievements in MEBO include 55 tissue organs such as gastrointestinal mucosa, pancreas, heart muscle, renal glomerulus, bone marrow, thymus,nerves and hair follicles. In the near future, cancer, diabetes and renal failure are on longer unconquerable diseases in humans. MEBO is leading us to step into a new life science domain that could change our future. MEBO will create outstanding medical miracles in human's regenerative medicine field!
The goal of MEBO International Group is to satisfy an increasing demand to improve the overall health and life quality of every individual in the world. Prolong human's life to 300 years old is the dream and ultimate goal of MEBO's people! MEBO International Group welcomes investors all over the world to contribute to the achievement of this promising mission! |
